TENM4 and breast carcinoma: The frequencies of ODZ4 gene amplifications in breast cancer patients have also been confirmed in the in silico analysis of a second dataset that compares primary tumors with normal, noncancerous samples and peripheral blood cells [74] (Figure 2A).